Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1371373 | Bioorganic & Medicinal Chemistry Letters | 2010 | 4 Pages |
Abstract
A novel series of glycine transporter 1 (GlyT1) inhibitors is described. Scoping of the heterocycle moiety of hit 4-chlorobenzenesulfonamide 1 led to replacement of the piperidine with an azepane for a modest increase in potency. Phenyl sulfonamides proved superior to alkyl and non-phenyl aromatic sulfonamides, while subsequent ortho substitution of the 2-(azepan-1-yl)-2-phenylethanamine aromatic ring yielded 39 (IC50 37 nM, solubility 14 μM), the most potent GlyT1 inhibitor in this series. Favorable brain–plasma ratios were observed for select compounds in pharmacokinetic studies to evaluate CNS penetration.
Graphical abstractA series of novel GlyT1 inhibitors is described.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Jeffrey G. Varnes, Janet M. Forst, Tiffany N. Hoerter, Christopher R. Holmquist, Deidre E. Wilkins, Gaochao Tian, Gerald Jonak, Xia Wang, William M. Potts, Michael W. Wood, Cristóbal Alhambra, Todd A. Brugel, Jeffrey S. Albert,